{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:14:59Z","timestamp":1777623299651,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11899-025-00761-2","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T05:55:55Z","timestamp":1762322155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasmacytoid Dendritic Cell-Expansion in Acute Myeloid Leukemia (pDC\u2011AML): a Review of Clinicopathologic Features, Genetics, and Outcomes"],"prefix":"10.1007","volume":"20","author":[{"given":"Azza E. A.","family":"Abdalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Abdulgayoom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman F.","family":"Al-Mashdali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firyal","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseema","family":"Gangat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehab F.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"761_CR1","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","volume":"284","author":"S FP","year":"1999","unstructured":"S. FP. The nature of the principal type I interferon-producing cells in human blood. Science. 1999;284:1835\u20137.","journal-title":"Science"},{"issue":"12","key":"761_CR2","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/ni1141","volume":"5","author":"M Colonna","year":"2004","unstructured":"Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5(12):1219\u201326.","journal-title":"Nat Immunol"},{"issue":"22","key":"761_CR3","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1007\/s00018-015-2005-0","volume":"72","author":"M O\u2019Keeffe","year":"2015","unstructured":"O\u2019Keeffe M, Mok WH, Radford KJ. Human dendritic cell subsets and function in health and disease. Cell Mol Life Sci. 2015;72(22):4309\u201325.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"761_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41590-018-0136-9","volume":"19","author":"PF Rodrigues","year":"2018","unstructured":"Rodrigues PF, Alberti-Servera L, Eremin A, Grajales-Reyes GE, Ivanek R, Tussiwand R. Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells. Nat Immunol. 2018;19(7):711\u201322.","journal-title":"Nat Immunol"},{"issue":"7","key":"761_CR5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41590-019-0420-3","volume":"20","author":"RJ Dress","year":"2019","unstructured":"Dress RJ, Dutertre CA, Giladi A, Schlitzer A, Low I, Shadan NB, et al. Plasmacytoid dendritic cells develop from Ly6D + lymphoid progenitors distinct from the myeloid lineage. Nat Immunol. 2019;20(7):852\u201364.","journal-title":"Nat Immunol"},{"issue":"20","key":"761_CR6","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/0008-5472.CAN-11-3468","volume":"72","author":"V Sisirak","year":"2012","unstructured":"Sisirak V, Faget J, Gobert M, Goutagny N, Vey N, Treilleux I, et al. Impaired IFN-\u03b1 production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression. Cancer Res. 2012;72(20):5188\u201397.","journal-title":"Cancer Res"},{"issue":"16","key":"761_CR7","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1158\/0008-5472.CAN-11-0367","volume":"71","author":"SI Labidi-Galy","year":"2011","unstructured":"Labidi-Galy SI, Sisirak V, Meeus P, Gobert M, Treilleux I, Bajard A, et al. Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res. 2011;71(16):5423\u201334.","journal-title":"Cancer Res"},{"issue":"22","key":"761_CR8","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1158\/1078-0432.CCR-04-0684","volume":"10","author":"I Treilleux","year":"2004","unstructured":"Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, Guastalla JP, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res. 2004;10(22):7466\u201374.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"761_CR9","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"key":"761_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/23247096251344723","volume":"13","author":"J Al-Nusair","year":"2025","unstructured":"Al-Nusair J, Porter N, Alagha Z, Graffeo V, Mahmud W, Alshal M. Nodal mature plasmacytoid dendritic cell proliferation in a patient with chronic myelomonocytic leukemia: a diagnostic mimic of blastic plasmacytoid dendritic cell neoplasm. J Invest Med High Impact Case Rep. 2025;13:23247096251344723.","journal-title":"J Invest Med High Impact Case Rep"},{"issue":"12","key":"761_CR11","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1182\/bloodadvances.2023012489","volume":"8","author":"T Mah\u00e9vas","year":"2024","unstructured":"Mah\u00e9vas T, Osio A, Larcher L, Clappier E, Kempf W, Ad\u00e8s L, et al. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms. Blood Adv. 2024;8(12):3293\u20138.","journal-title":"Blood Adv"},{"key":"761_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.104186","volume":"192","author":"J Peng","year":"2023","unstructured":"Peng J, He S, Yang X, Huang L, Wei J. Plasmacytoid dendritic cell expansion in myeloid neoplasms: a novel distinct subset of myeloid neoplasm? Crit Rev Oncol Hematol. 2023;192:104186.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"761_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bjd.12412","volume":"169","author":"F Julia","year":"2013","unstructured":"Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013;169(3):579\u201386.","journal-title":"Br J Dermatol"},{"issue":"5","key":"761_CR14","first-page":"257","volume":"21","author":"N Pemmaraju","year":"2023","unstructured":"Pemmaraju N, Kantarjian H. Blastic plasmacytoid dendritic cell neoplasm: emerging developments and special considerations for 2023. Clin Adv Hematol Oncol. 2023;21(5):257\u201364.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"2","key":"761_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.2012.072645","volume":"98","author":"L Pagano","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A, Fisogni S, Carluccio P, Mannelli F, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica. 2013;98(2):239.","journal-title":"Haematologica"},{"key":"761_CR16","doi-asserted-by":"crossref","unstructured":"Facchetti F, Ungari M, Marocolo D, Lonardi S, Vermi W. Blastic plasmacytoid dendritic cell neoplasm. In: Hematology Meeting Reports, vol 3, no 3 (formerly Haematologica Reports). 2009.","DOI":"10.4081\/hmr.v3i3.553"},{"issue":"11","key":"761_CR17","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328.","journal-title":"Blood"},{"key":"761_CR18","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1182\/blood-2018-99-119081","volume":"132","author":"W Xiao","year":"2018","unstructured":"Xiao W, Goldberg AD, Famulare C, Baik J, Gao Q, Tallman MS, et al. Acute myeloid leukemia with plasmacytoid dendritic cell differentiation: predominantly secondary AML, enriched for RUNX1 mutations, frequent cross-lineage antigen expression and poor prognosis. Blood. 2018;132:2789.","journal-title":"Blood"},{"issue":"14","key":"761_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143375","volume":"14","author":"W Wang","year":"2022","unstructured":"Wang W, Xu J, Khoury JD, Pemmaraju N, Fang H, Miranda RN, et al. Immunophenotypic and molecular features of acute myeloid leukemia with plasmacytoid dendritic cell differentiation are distinct from blastic plasmacytoid dendritic cell neoplasm. Cancers. 2022;14(14):3375.","journal-title":"Cancers"},{"issue":"5","key":"761_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00277-017-2947-4","volume":"96","author":"A Tzankov","year":"2017","unstructured":"Tzankov A, Hebeda K, Kremer M, Leguit R, Orazi A, van der Walt J, et al. Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th meeting of the European association for haematopathology (EAHP) organized by the European bone marrow working group, Basel 2016. Ann Hematol. 2017;96(5):765\u201377.","journal-title":"Ann Hematol"},{"issue":"12","key":"761_CR21","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3324\/haematol.2020.253740","volume":"106","author":"L Zalma\u00ef","year":"2020","unstructured":"Zalma\u00ef L, Viailly PJ, Biichle S, Cheok M, Soret L, Angelot-Delettre F, Petrella T, Collonge-Rame gn\u00e8s MA, Seilles E, Geffroy S, Deconinck E. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape. Haematologica. 2020;106(12):3056.","journal-title":"Haematologica"},{"issue":"1","key":"761_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cyto.a.23953","volume":"97","author":"Y Huang","year":"2020","unstructured":"Huang Y, Wang Y, Chang Y, Yuan X, Hao L, Shi H, et al. Myeloid neoplasms with elevated plasmacytoid dendritic cell differentiation reflect the maturation process of dendritic cells. Cytometry A. 2020;97(1):61\u20139.","journal-title":"Cytometry A"},{"issue":"1","key":"761_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cyto.b.21761","volume":"98","author":"F Hamadeh","year":"2020","unstructured":"Hamadeh F, Awadallah A, Meyerson HJ, Beck RC. Flow cytometry identifies a spectrum of maturation in myeloid neoplasms having plasmacytoid dendritic cell differentiation. Cytometry Part B: Clinical Cytometry. 2020;98(1):43\u201351.","journal-title":"Cytometry Part B: Clinical Cytometry"},{"issue":"10","key":"761_CR24","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1182\/blood.2020007897","volume":"137","author":"W Xiao","year":"2021","unstructured":"Xiao W, Chan A, Waarts MR, Mishra T, Liu Y, Cai SF, et al. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia. Blood. 2021;137(10):1377\u201391.","journal-title":"Blood"},{"issue":"7","key":"761_CR25","first-page":"7285","volume":"10","author":"P Wang","year":"2017","unstructured":"Wang P, Feng Y, Deng X, Liu S, Qiang X, Gou Y, et al. Tumor-forming plasmacytoid dendritic cells in acute myelocytic leukemia: a report of three cases and literature review. Int J Clin Exp Pathol. 2017;10(7):7285.","journal-title":"Int J Clin Exp Pathol"},{"issue":"15","key":"761_CR26","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.4103\/0366-6999.237404","volume":"131","author":"M Wang","year":"2018","unstructured":"Wang M, Chen YJ, Wang LR, Wang YZ, Lu J. Plasmacytoid dendritic cells proliferation coexisted with acute myeloid leukemia. Chin Med J. 2018;131(15):1866\u20137.","journal-title":"Chin Med J"},{"issue":"10","key":"761_CR27","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1007\/s00277-023-05377-1","volume":"102","author":"G Martino","year":"2023","unstructured":"Martino G, Cimino G, Caridi M, Perta G, Cardinali V, Sciabolacci S, et al. One disease, two faces: clonally-related AML and MPDCP with skin involvement. Ann Hematol. 2023;102(10):2969\u201371.","journal-title":"Ann Hematol"},{"issue":"01","key":"761_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/BS9.0000000000000097","volume":"4","author":"X Gong","year":"2022","unstructured":"Gong X, Li C, Wang Y, Rao Q, Mi Y, Wang M, Wei H, Wang J. Mature plasmacytoid dendritic cells associated with acute myeloid leukemia show similar genetic mutations and expression profiles to leukemia cells. Blood Sci. 2022;4(01):38\u201343.","journal-title":"Blood Sci"},{"issue":"5","key":"761_CR29","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","volume":"28","author":"W Vermi","year":"2004","unstructured":"Vermi W, Facchetti F, Rosati S, Vergoni F, Rossi E, Festa S, et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004;28(5):585\u201395.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"761_CR30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1365-2559.2012.04282.x","volume":"61","author":"HL Song","year":"2012","unstructured":"Song HL, Huang WY, Chen YP, Chang KC. Tumorous proliferations of plasmacytoid dendritic cells and Langerhans cells associated with acute myeloid leukaemia. Histopathology. 2012;61(5):974\u201383.","journal-title":"Histopathology"},{"key":"761_CR31","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.2147\/CMAR.S260825","volume":"6","author":"L Zhu","year":"2020","unstructured":"Zhu L, Wang P, Zhang W, Li Q, Xiong J, Li J, et al. Plasmacytoid dendritic cell infiltration in acute myeloid leukemia. Cancer Manag Res. 2020;6:11411\u20139.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"761_CR32","first-page":"1430","volume":"10","author":"YW Qian","year":"2023","unstructured":"Qian YW, Shalaby K, Griffiths EA, Fu K, Ali S. Plasmacytoid dendritic cell proliferation associated with acute myeloid Leukemia, case report and review of literature. Ann Hematol Onco. 2023;10(4):1430.","journal-title":"Ann Hematol Onco"},{"issue":"11","key":"761_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1600-0560.2011.01777.x","volume":"38","author":"JL Dargent","year":"2011","unstructured":"Dargent JL, Delannoy A, Pieron P, Husson B, Debecker C, Petrella T. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm. J Cutan Pathol. 2011;38(11):893\u20138.","journal-title":"J Cutan Pathol"},{"key":"761_CR34","volume":"22","author":"I Rashedi","year":"2024","unstructured":"Rashedi I, Abulkhair Y, Diehl E, Chang H. Diagnostic challenges in classification of plasmacytoid dendritic cell proliferation associated with acute myeloid leukemia in the context of secondary-type mutations. Leuk Res Rep. 2024;22:100480.","journal-title":"Leuk Res Rep"},{"key":"761_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106735","volume":"111","author":"S Chow","year":"2021","unstructured":"Chow S, Tang K, Al-Abri M, Hall V, Tremblay-Lemay R, Rashedi I, et al. RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed\/refractory acute myeloid leukemia. Leuk Res. 2021;111:106735.","journal-title":"Leuk Res"},{"issue":"17","key":"761_CR36","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","volume":"380","author":"N Pemmaraju","year":"2019","unstructured":"Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, et al. Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N Engl J Med. 2019;380(17):1628\u201337.","journal-title":"N Engl J Med"},{"issue":"3","key":"761_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/bloodadvances.2023011721","volume":"8","author":"AA Lane","year":"2024","unstructured":"Lane AA, Garcia JS, Raulston EG, Garzon JL, Galinsky I, Baxter EW, et al. Phase 1b trial of Tagraxofusp in combination with Azacitidine with or without venetoclax in acute myeloid leukemia. Blood Adv. 2024;8(3):591\u2013602.","journal-title":"Blood Adv"},{"issue":"3","key":"761_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1470-2045(23)00674-5","volume":"25","author":"NG Daver","year":"2024","unstructured":"Daver NG, Montesinos P, DeAngelo DJ, Wang ES, Papadantonakis N, Todisco E, et al. Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody\u2013drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1\/2 study. Lancet Oncol. 2024;25(3):388\u201399.","journal-title":"Lancet Oncol"},{"issue":"21","key":"761_CR39","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1182\/bloodadvances.2023010956","volume":"7","author":"F Ravandi","year":"2023","unstructured":"Ravandi F, Bashey A, Foran J, Stock W, Mawad R, Short N, et al. Phase 1 study of Vibecotamab identifies an optimized dose for treatment of relapsed\/refractory acute myeloid leukemia. Blood Adv. 2023;7(21):6492\u2013505.","journal-title":"Blood Adv"},{"issue":"2","key":"761_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bneo.2025.100066","volume":"2","author":"M Boichut","year":"2025","unstructured":"Boichut M, Poussard M, Roussel X, Belakri I, Biichl\u00e9 S, Fredon M, et al. New leads to enhance Tagraxofusp efficacy in pDC-AML. Blood Neoplasia. 2025;2(2):100066.","journal-title":"Blood Neoplasia"},{"issue":"2","key":"761_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12185-024-03902-0","volume":"121","author":"F Magnoli","year":"2025","unstructured":"Magnoli F, Brociner M, La Rosa S. Nodal mature plasmacytoid dendritic cell proliferation mimicking lymphoma in a patient with CALR-mutated myelofibrosis. Int J Hematol. 2025;121(2):147\u20138.","journal-title":"Int J Hematol"},{"key":"761_CR42","doi-asserted-by":"crossref","unstructured":"Vannucchi M, Siciliano MC, Granai M, Ferrara D, Boccacci R, Lori C, Tarantino D, Signori L, Guglielmelli P, Leoncini L, Lazzi S. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) and mature plasmacytoid dendritic cell proliferation (MPDCP): the same cell of origin from a clonal haematopoiesis of indeterminate potential (CHIP)? Histopathology. 2025 Oct;87(4):624\u20137.","DOI":"10.1111\/his.15516"},{"issue":"16","key":"761_CR43","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1002\/cncr.34345","volume":"128","author":"IJ Adimora","year":"2022","unstructured":"Adimora IJ, Wilson NR, Pemmaraju N. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a promising future in the era of targeted therapeutics. Cancer. 2022;128(16):3019\u201326.","journal-title":"Cancer"},{"issue":"4","key":"761_CR44","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/hematolrep15040070","volume":"15","author":"G Cazzato","year":"2023","unstructured":"Cazzato G, Capuzzolo M, Bellitti E, De Biasi G, Colagrande A, Mangialardi K, et al. Blastic plasmocytoid dendritic cell neoplasm (BPDCN): clinical features and histopathology with a therapeutic overview. Hematol Rep. 2023;15(4):696\u2013706.","journal-title":"Hematol Rep"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-025-00761-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-025-00761-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-025-00761-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:03:22Z","timestamp":1769051002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-025-00761-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["761"],"URL":"https:\/\/doi.org\/10.1007\/s11899-025-00761-2","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Was not required for this study, as it is based exclusively on published literature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}